Coronary artery aneurysms (CAAs) are incidentally revealed by coronary angiography and consist in a localized dilation of a coronary artery. Although invasive coronary angiography (ICA) is the gold standard imaging technique, it can lead to the underestimation of CAAs diameter in presence of parietal thrombi. Computed tomography coronary angiography (CTCA) is a very sensitive tool in CAAs detection and provides a clear visualization of coronary lumen highlighting intraluminal thrombi.
Introduction
Coronary artery aneurysms (CAAs) are rare findings diagnosed incidentally in patients undergoing invasive coronary angiography (ICA) 1 with an incidence ranging from 0.3% to 5%. [2] [3] [4] [5] [6] [7] This pathology is characterized by a localized dilation of a coronary artery 1.5 times the diameter of the adjacent normal segment [8] [9] [10] . ICA remains the gold standard 11, 12 for CAAs detection and allows both therapeutic and diagnostic intervention; nevertheless, in case of thrombus or occlusion, an underestimation of the real size may occur until to be undetectable. [13] [14] [15] Computed tomography coronary angiography (CTCA) is a wide available and non-invasive imaging technique that provides a morphologic visualization of coronary arteries highlighting aneurysms in addition to stenoses and plaques composition (calcified and non-calcified). Descriptions of CAAs on CTCA are mainly based on isolated case reports 1, [16] [17] [18] or studies in patients affected by Kawasaki disease 19, 20 and
Takayasu arteritis 21 while a broad literature is available about aneurysms revealed by ICA. 5, [22] [23] [24] [25] Our purpose is to study the prevalence of CAAs in the population referred to our institution for CTCA, to analyse patient's clinical characteristics and aneurysmal coronary features and to compare clinical variables and imaging findings in aneurysmal and non-neurysmal groups of patients.
Methods

Patient population and selection
We retrospectively evaluated 390 consecutive CTCAs performed from 2007 to 2015 for suspected coronary artery disease (CAD) or follow-up after myocardial ischemia. 18 CTCAs with severe artefacts, mainly due to heart rate variability, motion or breathing, were removed from the study. Patients were divided into aneurysmal (A) and non-aneurysmal group (NA) depending on the presence of CAAs. The NA group included patients with healthy coronaries to CTCA (18.82%) and patients with CAD (calcifications, stents and by-pass) but not showing aneurysmal dilations (81.18%). For the 9 patients in the A group, matched controls were identified in the non-aneurysmal healthy coronaries group (NAH) according to clinical variables and medical histories, including risk factors as family history, smoke, diabetes, hyperlipidemia, hypertension and, in addition, body mass index (BMI), heart rate (HR), and symptoms. Clinical characteristics are reported in Table 1 . 5 patients in A group (55.5%) and 3 patient in NAH group (33.3%) had previously performed an ICA. A retrospective case-control analysis was conducted.
All screened patients provided written informed consent and the study received ethical approval from the appropriate Human Investigations Committee and complies with the Declaration of Helsinki.
Computed tomography scan protocol and image reconstruction
All coronary CTCA examinations were performed on a CT scanner (Discovery CT750 HD, GE Healthcare), with a 64 Â 0.625 mm collimation, rotation time 350 ms, temporal resolution 228 ms. Patients with a HR above 65 bpm performed a home therapy with a beta-blocker or calcium channel blockers according to cardiologist indications and reached appropriate pre-scan HR below 65 bpm. A prospective ECG-triggered scan without contrast medium was used for calcium score evaluation followed by a prospective or retrospective scan according to HR. Contrast enhancement was obtained by a bolus tracking technique with scan starting when a region of interest placed in the ascending aorta at the pulmonary bifurcation reached a threshold of 100 HU. Contrast material (iomeprol 400 mg I/mL, Iomeron 400, Bracco, Milan, Italy) was injected at 5-6 mL/s through an 18-gauge intravenous antecubital catheter and was followed by 40 mL of saline solution at the same flow. 
Computed tomography data analysis and measurements
A radiologist and a cardiologist in consensus evaluated the images. In detail, for the A group, the length and maximum diameter of the aneurysms were analysed. The total vessel length and the cross-sectional diameter of the aneurysmal vessels in the pre-aneurysmal segment were also measured; moreover, the mean diameter of the left main coronary artery (LM), left anterior descending coronary artery (LAD), left circumflex coronary artery (CX), right coronary artery (RCA), ascending aorta and thoracic aorta were calculated at 1 cm from the vessel origin for both the A and the NAH group. Finally, the ratio between the pre-aneurysmal diameter and the aneurysmal diameter was computed together with the ratio between the aneurysmal length and the total vessel length. The preaneurysmal and maximum aneurysmal diameter were also measured on ICA where available. Each measure was taken by the two blinded operators and averaged values were considered for the statistical analysis.
Statistical analysis
Statistical analysis was performed using R Core Team (version 3.03 Austria, Vienna). Continuous variables were expressed as mean 6 standard deviation. Unpaired t test was used for comparison between the two groups after testing normality through the Shapiro-Wilk test and homoscedasticity through the Levene test. Categorical variables were compared using the Fisher's exact test. The Pearson correlation test was performed to assess linear relationship between variables. A P < 0.05 was considered for statistical significance.
Results
The A group was composed by 9 patients with CAAs (6 men and 3 women, representing 2.31% of all CTCA studied patients), 1 of these presented multiple aneurysms (7 aneuryms: 1 aneurysm on CX and 6 aneurysms on RCA) ( Figure 1 ). There were, in total, 15 aneurysms; 9 were located on RCA, 3 on CX and 3 on LAD. For all the cases, the ratio between the aneurysmal diameter and the pre-aneurysmal diameter was greater than 1.5 and the ratio between the aneurysmal length and the total vessel length was lower than 0. 5 . Results are showed in Table 2 . The total mean length was 22.59 6 12.09 mm and the total mean diameter was 9.83 6 4.05 mm; results are summarized in Table 3 . 77.7% of patients were asymptomatic while 22.3% presented an atypical chest pain. five patients belonging to A group had previously performed an ICA: 2 patients were rightly diagnosed CAAs (case 1 and 8), 1 patient was diagnosed a coronary artery ectasia (case 4) and 2 patients resulted as false negative for CAAs (case 6 and 7) mainly due to thrombotic stenosis ( Table 2) . In 6 patients (66.7%) CTCA displayed an aneurysmal thrombosis ( Figure 2) ; 2 patients (22.2%) showed 0 calcium score calculated according to Agatston method, in 5 patients (55.5%) aneurysms were associated to coronary artery stenoses and 2 of these presented significant stenoses (> 50%) with severe calcification. 1 patient, suffering from Marfan syndrome, (Figures 3 and 4) . No significant correlation was found between vessels diameters and age or BMI.
Discussion
The development of ICA has significantly increased the in vivo detection of CAAs, whereas previous studies were conducted only postmortem. 2, 27 The technological improvements of computed tomography have confirmed it as a powerful tool for coronary disease detection such as CAAs. Compared to ICA, it allows to visualize the lumen of the coronaries, aneurysmal size, and shape are well Coronary anuerysms by CTCA assessed and intraluminal thrombi or occlusions can be easily displayed. 1, 8 CTCA yields a versatile post-processing: maximum intensity projections (MIP), curved multiplanar reformations (c-MPR) and 3D volume rendering clearly identify the anatomical relationships of the aneurysm with the surrounding structures. 28 An appropriate imaging assessment should provide a correct identification of aneurysms, in particular number, location, shape, size, intraluminal thrombi, occlusions, and associated stenoses. 13 Kanamaru and colleagues 20 demonstrated that CTCA has a 100% sensitivity in CAAs detection; a 87.5% sensitivity and a 92.5% specificity were found for significant coronary artery stenoses and occlusions detection. Cademartiri and colleagues 29, 30 reported a CAAs prevalence of 2% and 1.6%, respectively, in 2 comprehensive studies focused on coronary variants and anomalies by 64 slice CTCA.
In accordance with these results, we found a prevalence of 2.31%; males resulted more affected than women (66.7% vs. 33 .3%). In our population all aneurysmal patients presented an aneurysmal diameter that exceeds 1.5 times the pre-aneurysmal diameter and CAA involves less than 50% of the total length vessel, according to the definition proposed by Zamudio et al 13 for coronary aneurysms and ectasia.
Coronary artery aneurysms can have several clinical manifestations since some patients are asymptomatic but others refer anginal pain; 16 in our case, 77.7% of the patients were asymptomatic and 22.3% had atypical chest pain.
Coronary artery aneurysms are often related to a broad spectrum of diseases such as atherosclerosis, connective tissue diseases (scleroderma, systemic lupus erythematosus, rheumatoid arthritis, Loeys-Dietz syndrome), systemic vasculitis (Kawasaki disease, Behçet disease, Takayasu aortitis, polyarteritis nodosa) and collagen genetic syndromes (Ehlers-Danlos syndrome, Marfan syndrome). 16, 31, 32 Atherosclerosis is the most common etiology, in fact 50% of CAAs are ascribed to CAD while 20-30% are considered to be congenital and only 10-20% are associated to inflammatory or connective tissue diseases; 33 in our population, CAAs were associated to atherosclerosis in 55.5% of the cases and to a connective tissue disease in 11.1%, while in 33.4% the etiology was unknown; no aneurysm was caused by previous surgical procedures. Although atherosclerosis represents the main cause of CAAs, in our population there were no differences in plaque distribution and morphology between aneurysmal and non-aneurysmal patients. This finding could be explained considering that CAD is a systemic disease and involves coronaries regardless of the presence of aneurysms on themselves. RCA is the most affected vessel (40-61%), as demonstrated by several authors, 3, 10, 12, 13, 22, 27 followed by LAD (15-32%) and CX (15-23%) while LM involvement is very rare. Our results, in agreement with these findings, showed that CAAs for 60% were located on RCA, for 20% on LAD and for 20% on CX, no aneurysm was found on LM. In 66.7% of the cases CTCA revealed intraluminal thrombi, displaying its advantages on ICA. 1 Although only 5/9 patients were admitted to our institution with a previous ICA exam, the comparison between vessel diameters in both the preaneurysmal and aneurysmal segment revealed a rate of underestimation in 3/5 cases compared to CTCA. This finding is related to the inability of ICA to correctly identify CAAs with intraluminal thrombi or plaque, allowing only a visualization of the lumen and not an accurate characterization of the vascular wall, as CTCA. These shortcomings of ICA have been extensively discussed by many authors. 28, 34 Atherosclerotic CAAs are usually multiple and involve more than one vessel, 23, 24, 35 in our population, 1 patient (11.1%) presented 7
aneursyms (1 aneurysm on CX and 6 aneurysms on RCA) associated with intraluminal thrombi and significant stenoses. The significant difference between the mean coronaries diameters in the healthy segments in A and NAH group confirm the multi-vessel and polyaneurysmal nature of CAAs. Our study had some limitations. The small number of patients suffering from CAAs, due to the low prevalence of CAAs, has limited the statistical power of this study. Despite the small size of the sample and the low output of the Centre, CTCA showed an undoubted diagnostic usefulness on CAA evaluation. Moreover, other parameters such as laboratory markers (cholesterol, glycaemia, etc) or blood pressure were not available and a correlation study between physiological values was not possible. In population with greater pretest probability of CAAs, for example patients affected by connective tissue disorders or systemic vasculitis such as Kawasaki disease or Takayasu arteritis, we would have expected a higher prevalence of CAAs, as previously reported (for example, 38.6% and 8.1% for Kawasaki and Takayasu disease, respectively.
21,36
Conclusion
In our setting, 2.31% of the patients who underwent CTCA showed CAAs. Atherosclerosis was the most common etiology and RCA resulted the most affected vessel with the 66.7% of patients presenting intraluminal thrombi detected by CTCA. This technique provided a clear visualization of the coronary anatomy and CAA features, sometimes overcoming ICA findings, when available.
